Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx

Carcinomas do rarely metastasize to the finger. Non‐small‐cell lung cancer is most frequently involved. To date, only a few cases have been reported, on histology. Here we describe the cytological features of a metastatic lung adenocarcinoma case to the phalanx of the right forefinger as initial manifestation of the neoplastic disease in a 69‐years‐old woman. The cytological microscopic findings, complemented by a wide array of ancillary techniques, were confirmed by histology. Neoplastic cells were positive for cytokeratin 7 (CK7) and thyroid transcription factor 1 (TTF‐1), harboring, in tissue and in bloodstream samples, an uncommon epidermal growth factor receptor (EGFR) exon 20 p.S768_D760DUP, detected by next generation sequencing (NGS) and liquid biopsy. Cytology corroborated by immunocytochemistry, NGS, and liquid biopsy is a modern approach to provide diagnostic and therapeutic information even in rare and challenging cases.

[1]  A. Russo,et al.  The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal. , 2020, Cancer treatment reviews.

[2]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[3]  Joe Y. Chang,et al.  NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  G. Troncone,et al.  EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review , 2018, Translational cancer research.

[5]  G. Troncone,et al.  Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples , 2018, Journal of Clinical Pathology.

[6]  L. Sequist,et al.  Response to Osimertinib in an EGFR Exon 20 Insertion-Positive Lung Adenocarcinoma. , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  S. Novello,et al.  Pembrolizumab plus Chemotherapy in Metastatic Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[8]  B. Sundaram,et al.  Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecula , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Robyn L. Temple-Smolkin,et al.  Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. , 2018, Archives of pathology & laboratory medicine.

[10]  G. Troncone,et al.  Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. , 2017, Journal of thoracic disease.

[11]  R. Rosell,et al.  Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients , 2017, British Journal of Cancer.

[12]  S. Das,et al.  Digital Acrometastasis as Initial Presentation in Carcinoma of Lung A Case Report and Review of Literature. , 2016, Journal of clinical and diagnostic research : JCDR.

[13]  B. Biondi,et al.  Cytopathologists can reliably perform ultrasound‐guided thyroid fine needle aspiration: a 1‐year audit on 3715 consecutive cases , 2016, Cytopathology : official journal of the British Society for Clinical Cytology.

[14]  K. Ozkan,et al.  Lung Metastasis Mimicking Fingertip Infection , 2015, Case reports in oncological medicine.

[15]  F. Paganin,et al.  Radiotherapy for a Phalanx Bone Metastasis of a Lung Adenocarcinoma , 2014, Case Reports in Oncology.

[16]  G. Troncone,et al.  EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients , 2013, Cancer cytopathology.

[17]  G. da Cunha Santos,et al.  “The petals and thorns” of ROSE (rapid on‐site evaluation) , 2013, Cancer cytopathology.

[18]  R. Laucirica,et al.  Digital acrometastasis: a rare initial sign of occult pulmonary squamous cell carcinoma. , 2009, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[19]  J. Rubenstein,et al.  Two cases of acrometastasis to the hands and review of the literature , 2008, Current oncology.

[20]  R. Kerin The hand in metastatic disease. , 1987, The Journal of hand surgery.